Catherine Moukheibir
Director · MoonLake Immunotherapeutics
- 2025
- Jun 18, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Catherine Moukheibir files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- Alexander J. Denner - $20.53M in IRWD purchases and sales in the last 12 months
- da Silva Jorge Santos - $8.73M in MLTX purchases and sales in the last 12 months
- Kristian Reich - $8.14M in MLTX purchases and sales in the last 12 months
- Matthias Bodenstedt - $3.20M in MLTX purchases and sales in the last 12 months
- Ronald Silver - $831K in IRWD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Catherine Moukheibir?
Catherine Moukheibir is a corporate insider, tracked as Director of MoonLake Immunotherapeutics (MLTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Catherine Moukheibir last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 3 filings going back to 2025.
Has Catherine Moukheibir been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1.15M) across all tracked filings.
